National Cancer Centre, Singapore

This small, early-stage study tested whether a drug called bexarotene could make chemotherapy work better for people with a hard-to-treat, resistant form of metastatic breast cancer. Researchers enrolled 12 patients whose cancer had stopped responding to standard taxane drugs. Th…

This study tested if adding a drug called pembrolizumab to standard pre-surgery treatments could help the body's immune system fight colorectal cancer. It involved 33 patients with non-metastatic colon or rectal cancer who received the immunotherapy along with their usual chemoth…

This study tested a 6-month coaching program designed to help heart failure patients and their family caregivers better manage the challenges of the illness. The program provided education and support to improve quality of life and coping skills. Researchers wanted to see if this…

This study looked at how eating durian fruit affects the gut and body in healthy people. Forty-five volunteers ate a controlled amount of durian daily for two weeks while following a special diet. Researchers collected stool and blood samples to see if durian changed their gut ba…

This study analyzed data from 1,043 patients who had surgery for liver cancer between 2000 and 2018. Researchers created a prediction tool to estimate 5-year survival chances based on tumor size, number, and blood test results. The study also compared outcomes between open and la…